Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

13 articles

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

Cannabis and cannabinoids: Cancer risk and use to manage cancer symptoms

Document Status: Current
ID: N/A
Version: 2

Jan 2023

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Document Status: Current
ID: GL 21-6

Apr 2023

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2023

Document Status: Current
ID: PET 2023-1

Updated

Nov 2023

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2022

Document Status: Current
ID: PET 2022-2

Jun 2023

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Document Status: Current
Version: 1

Apr 2023

Management of Early-Stage Hodgkin Lymphoma

Document Status: Current
ID: GL 6-20
Version: 2

May 2023

Ontario Health (Cancer Care Ontario) Endorsement of ASCO Rapid Recommendation on 177Lutetium-Prostate-Specific Membrane Antigen-617 (PSMA-617) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Document Status: Current
ID: GL-END 3-25

Updated

Nov 2023

Optimizing Ambulatory Systemic Treatment Models of Care

Document Status: Current
Version: 1

Jul 2023

Patient Safety Issues: Key Components of Intravenous Systemic Cancer Therapy Labelling

Document Status: Current
ID: 12-11
Version: 2

Apr 2023

Preoperative Breast Magnetic Resonance Imaging

Document Status: Current
ID: GL 1-25
Version: N/A

Mar 2023

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Document Status: Current
ID: 7-A-2022-1-17v3
Version: 3

Oct 2023